Quantcast

Latest pharmaceutical industry Stories

2014-08-11 12:27:45

AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Ferring Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis, Novo Nordisk, Pearl Therapeutics, Pfizer, Sanofi, Chiltern International, ICON plc, INC Research, inVentiv Health, Parexel International, Pharmaceutical Research Associates (PRA), Quintiles, and Target Health Inc. ELLICOTT CITY, Md., Aug. 11, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing...

2014-08-11 08:30:05

All studies on track for completion and final study reports by November 2014 MALVERN, Pa., Aug. 11, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of late-stage pharmaceutical products focused on the treatment of pain, announced today that it has completed patient enrollment for the dermal safety studies and the pivotal pharmacokinetic study related to its investigational product Ztlido (lidocaine patch 1.8%), a...

2014-08-11 08:28:51

With CE mark in place and FDA-directed studies underway in US, company accelerates market development efforts in US, Canada, Israel, and multiple countries in Europe ENGLEWOOD, Colo., Aug. 11, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that subsidiary Luoxis Diagnostics has expanded its academic and pharmaceutical research network to over 25 sites around the world. To date the company has initiated over 17 scientific and clinical research...

2014-08-11 08:28:44

PITTSBURGH, Aug. 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.(1) CEO...

2014-08-09 23:01:36

The molecular diagnostics market is categorized on the basis of application, technology, end user, product, and geography. http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html (PRWEB) August 09, 2014 The "Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to...

2014-08-08 23:00:24

The Pharmaceuticals Packing and Labeling Services industry has performed well over the past five years, with minor losses in 2009; and over the next five years, strong growth will continue as the number of individuals will healthcare increases and as patents on brand name drugs expire, causing the industry will benefit from generic manufacturers that will need industry services. For these reasons, industry research firm IBISWorld has added a report on the Pharmaceuticals Packing and...

2014-08-08 20:22:07

CHAPEL HILL, N.C., Aug. 8, 2014 /PRNewswire/ -- Medical education leaders in the medical device and pharmaceutical sectors are finding it challenging to navigate the current regulatory and financial landscape. These challenges - one affecting program content and delivery and the other affecting resources - have made it even more important for medical education groups to effectively reach physicians and to efficiently use their resources. To help medical education leaders succeed in this...

2014-08-08 12:25:01

DUBLIN, Aug. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diabetic Neuropathy Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 R&D activities in the Diabetic Neuropathy sector are growing in terms of an increase in the number of mergers and acquisitions. Big pharmaceutical companies take up later-stage products from small companies, where efficacy has already been demonstrated, thereby cutting down...

2014-08-08 08:25:49

TAMPA, Fla., Aug. 8, 2014 /PRNewswire-USNewswire/ -- ISPE announced today that its Quality Metrics Pilot Program has achieved a major milestone with confirmation of 12 companies and 32 sites participating in the Program, even as recruitment continues. In line with an objective of the Pilot Program, the companies represent generic, innovator, over-the-counter, contract manufacturing and analytical businesses with a good spread of technologies - solid dosage, sterile, drug substance, small and...

2014-08-08 08:25:48

THE WOODLANDS, Texas, Aug. 8, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Wedbush Life Sciences Management Access Conference on Tuesday, August 12, 2014 at 10:55 AM EDT in New York City. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones. A webcast of the presentation will be available through Lexicon's website at www.lexpharma.com. An archived...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related